- $7.31bn
- $11.67bn
- $828.11m
- 68
- 58
- 73
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 670 | 661 | 726 | 773 | 828 |
Cost of Revenue | |||||
Gross Profit | 643 | 632 | 698 | 747 | 800 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 254 | 303 | 298 | 290 | 273 |
Operating Profit | 417 | 358 | 428 | 483 | 555 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 300 | 229 | 290 | 335 | 392 |
Net Income After Taxes | 300 | 229 | 290 | 335 | 392 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 299 | 229 | 290 | 335 | 392 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 258 | 210 | 264 | 334 | 392 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.56 | 1.45 | 1.62 | 1.88 | 1.95 |
Dividends per Share |